These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21681099)

  • 21. Mesenchymal stem cell therapy in lung disorders: pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell.
    Inamdar AC; Inamdar AA
    Exp Lung Res; 2013 Oct; 39(8):315-27. PubMed ID: 23992090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.
    Vija L; Farge D; Gautier JF; Vexiau P; Dumitrache C; Bourgarit A; Verrecchia F; Larghero J
    Diabetes Metab; 2009 Apr; 35(2):85-93. PubMed ID: 19230736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late-outgrowth endothelial cells attenuate intimal hyperplasia contributed by mesenchymal stem cells after vascular injury.
    Wang CH; Cherng WJ; Yang NI; Kuo LT; Hsu CM; Yeh HI; Lan YJ; Yeh CH; Stanford WL
    Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):54-60. PubMed ID: 17991877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesenchymal stromal cells.
    Bernardo ME; Locatelli F; Fibbe WE
    Ann N Y Acad Sci; 2009 Sep; 1176():101-17. PubMed ID: 19796238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal stem cell interactions with growth factors on kidney repair.
    Baer PC; Geiger H
    Curr Opin Nephrol Hypertens; 2010 Jan; 19(1):1-6. PubMed ID: 19838114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model.
    Semedo P; Correa-Costa M; Antonio Cenedeze M; Maria Avancini Costa Malheiros D; Antonia dos Reis M; Shimizu MH; Seguro AC; Pacheco-Silva A; Saraiva Camara NO
    Stem Cells; 2009 Dec; 27(12):3063-73. PubMed ID: 19750536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concise review: mesenchymal stromal cells: potential for cardiovascular repair.
    Psaltis PJ; Zannettino AC; Worthley SG; Gronthos S
    Stem Cells; 2008 Sep; 26(9):2201-10. PubMed ID: 18599808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
    González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
    Arthritis Rheum; 2009 Apr; 60(4):1006-19. PubMed ID: 19333946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges in pulmonary fibrosis: 7--Novel therapies and lung transplantation.
    Williams TJ; Wilson JW
    Thorax; 2008 Mar; 63(3):277-84. PubMed ID: 18308963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adult stem cells for chronic lung diseases.
    Mora AL; Rojas M
    Respirology; 2013 Oct; 18(7):1041-6. PubMed ID: 23648014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal stem cells for repair of the airway epithelium in asthma.
    Knight DA; Rossi FM; Hackett TL
    Expert Rev Respir Med; 2010 Dec; 4(6):747-58. PubMed ID: 21128750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesenchymal stem cells and bone regeneration: current status.
    Jones E; Yang X
    Injury; 2011 Jun; 42(6):562-8. PubMed ID: 21489533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential of mesenchymal stem cells as immune therapy in solid-organ transplantation.
    Crop M; Baan C; Weimar W; Hoogduijn M
    Transpl Int; 2009 Apr; 22(4):365-76. PubMed ID: 19000235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
    Schena F; Gambini C; Gregorio A; Mosconi M; Reverberi D; Gattorno M; Casazza S; Uccelli A; Moretta L; Martini A; Traggiai E
    Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization and biodistribution of human mesenchymal stem cells transduced with lentiviral-mediated BMP2.
    Choi KS; Ahn SY; Kim TS; Kim J; Kim BG; Han KH; Ban SJ; Kim HS; Choi Y; Lim CJ
    Arch Pharm Res; 2011 Apr; 34(4):599-606. PubMed ID: 21544725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases.
    Ben-Ami E; Berrih-Aknin S; Miller A
    Autoimmun Rev; 2011 May; 10(7):410-5. PubMed ID: 21256250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological properties of mesenchymal stem cells and clinical implications.
    Patel SA; Sherman L; Munoz J; Rameshwar P
    Arch Immunol Ther Exp (Warsz); 2008; 56(1):1-8. PubMed ID: 18250975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.
    Senoo T; Hattori N; Tanimoto T; Furonaka M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Yokoyama A; Kohno N
    Thorax; 2010 Apr; 65(4):334-40. PubMed ID: 20388759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction.
    Hahn JY; Cho HJ; Kang HJ; Kim TS; Kim MH; Chung JH; Bae JW; Oh BH; Park YB; Kim HS
    J Am Coll Cardiol; 2008 Mar; 51(9):933-43. PubMed ID: 18308163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine.
    Caplan AI
    J Cell Physiol; 2007 Nov; 213(2):341-7. PubMed ID: 17620285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.